3004.20.00.76/Meropenem 500mg Intravenous Injection Vial/Canada

Meropenem 500mg Intravenous Injection Vial from Canada

This is a sterile, single-dose vial containing 500mg of meropenem powder for reconstitution into a solution for intravenous administration to treat severe bacterial infections. It falls under HTS 3004.20.00.76 as a medicament containing meropenem, put up in measured doses for therapeutic use against antibiotic-resistant bacteria. The product is unmixed meropenem or its salts, specifically formulated for hospital IV delivery.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Obtain FDA approval and provide Certificate of Pharmaceutical Product (CPP) from the manufacturing country for import clearance

• Verify batch-specific stability data and ensure cold chain logistics to maintain potency during transit

• Avoid misclassification by confirming the product contains only meropenem or its salts without other active ingredients